Nuclear accumulations of p53 and Mdm2 are accompanied by reductions in c-Abl and p300 in zinc-depleted human hepatoblastoma cells

Experimental Biology and Medicine

Volumn 231, Issue 5, 2006, Pages 611-618

  Alshatwi, Ali A ^a   Han, Chung Ting ^a   Schoene, Norberta W ^b   Lei, Kai Y ^a,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^c 0112 Skinner Building ^*  (United States)

Author keywords

c Abl; Mdm2; p300; p53; Zinc deficiency

Indexed keywords

ABELSON KINASE; DNA; HISTONE ACETYLTRANSFERASE PCAF; MDM2 PROTEIN, HUMAN; PROTEIN MDM2; PROTEIN P53; ZINC;

ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CHEMISTRY; HEPATOBLASTOMA; HUMAN; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; DNA; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; P300-CBP TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-MDM2; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 33744978775     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100516     Document Type: Article

References (36)

1. Donehower LA. Effects of p53 mutation on tumor progression: recent insights from mouse tumor models. Biochim Biophys Acta 1242:171-176, 1996.
2. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 88:323-331, 1997.
3. El-Deiry WS. p21/p53, cellular growth control and genomic integrity. Curr Top Microbiol Immunol 227:121-137, 1998.
4. Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee EY. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18:7883-7899, 1999.
5. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597, 1992.
6. Picksley SM, Lane DP. The p53-MDM2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53? Bioessays 15: 689-690, 1993.
7. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275:8945-8951, 2000.
8. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299, 1997.
9. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 387:299-303, 1997.
10. Shirangi TR, Zaika A, Moll UM. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J 16:420-422, 2002.
11. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 2:405-415, 1998.
12. Lai Z, Ferry KV, Diamond MA, Wee KE, Kim YB, Ma J, Yang T, Benfield PA, Copeland RA, Auger KR. Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J Biol Chem 276:31357-31367, 2001.
13. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM. Polyubiquitination of p53 by a ubiquitin ligase of p300. Science 300:342-344, 2003.
14. Sharp DA, Kratowicz SA, Sank MJ, George DL. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J Biol Chem 274:38189-38196, 1999.
15. Scheffner M. Ubiquitin, E6-AP and their role in p53 inactivation. Pharmacol Ther 78:129-139, 1998.
16. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB, Wang JY. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387:516-519, 1997.
17. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Walters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin M. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387:520-523, 1997.
18. Wang JY. Regulation of cell death by the Abl tyrosine kinase. Oncogene 19:5643-5650, 2000.
19. Sionov RV, Coen S, Goldberg Z, Berger M, Bercovich B, Ben-Neriah Y, Ciechanover A, Haupt Y. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol Cell Biol 21:5869-5878, 2001.
20. Goldberg Z, Vogt Sionov R, Berger M, Zwang Y, Perets R, Van Etten RA, Oren M, Taya Y, Haupt Y. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J 21:3715-3727, 2002.
21. Fanzo JC, Reaves SK, Cui L, Zhu L, Wu JY, Wang YR, Lei KY. Zinc status affects p53, gadd45, and c-fos expression and caspase-3 activity in human bronchial epithelial cells. Am J Physiol Cell Physiol 281: C751-C757, 2001.
22. Fanzo JC, Reaves SK, Cui L, Zhu L, Lei KY. p53 protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells. Am J Physiol Cell Physiol 283:C631-C638, 2002.
23. Reaves SK, Fanzo JC, Arima K, Wu JYJ, Wang YR, Lei KY. Expression of the p53 tumor suppressor gene is upregulated by depletion of intracellular zinc in HepG2 cells. J Nutr 130:1688-1694, 2000.
24. Wu JYJ, Wu Y, Reaves SK, Wang YR, Lei PP, Lei KY. Apolipoprotein A-I gene expression is regulated by cellular zinc status in HepG2 cells. Am J Physiol 277:C537-C544, 1999.
25. Williams DL, Newman TC, Shelness GS, Gordon DA. Measurement of apolipoprotein mRNA by DNA-excess solution hybridization with single-stranded probes. Methods Enzymol 128:671-689, 1986.
26. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419-6421, 1989.
27. Cui L, Schoene NW, Zhu L, Fanzo JC, Alshatwi A, Lei KY. Zinc depletion reduced Egr-1 and HNF-3beta expression and apolipoprotein A-I promoter activity in Hep G2 cells. Am Physiol Cell Physiol 283: C623-C630, 2002.
28. Chesters JK, Petrie L, Lipson KE. Two zinc-dependent steps during G1 to S phase transition. J Cell Physiol 155:445-451, 1993.
29. Nakatani T, Tawaramoto M, Opare Kennedy D, Kojima A, Matsui-Yuasa I. Apoptosis induced by chelation of intracellular zinc is associated with depletion of cellular reduced glutathione level in rat hepatocytes. Chem Biol Interact 125:151-163, 2000.
30. Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol 20:8458-8467, 2000.
31. Kapoor M, Hamm R, Yan W, Taya Y, Lozano G. Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene 19:358-364, 2000.
32. Migliorini D, Denchi EL, Danovi D, Jochemsen A, Capillo M, Gobbi A, Helin K, Pelicci PG, Marine JC. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol Cell Biol 22:5527-5538, 2002.
33. Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett 447:5-9, 1999.
34. Stad R, Little NA, Xirodimas DP, Frenk R, Van der Eb AJ, Lane DP, Saville MK, Jochemsen AG. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep 2:1029-1034, 2001.
35. Sun X, Majumder P, Shioya H, Wu F, Kumar S, Weichselbaum R, Kharbanda S, Kufe D. Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem 275:17237-17240, 2000.
36. Pickart CM. Ubiquitin in chains. Trends Biochem Sci 25:544-548, 2000.